|
Specific abbreviations |
Explanation |
| APC |
Activated protein C |
| APTT |
Activated partial thromboplastin time |
| C |
Cohort study |
| CC |
Case‐control study |
| COC |
Combined oral contraceptive |
| CT |
Computed axial tomography |
| DVT |
Deep‐vein thrombosis |
| MRI |
Magnetic resonance imaging |
| NA |
Not applicable |
| NCC |
Nested case‐control study |
| PCS |
Prospective cohort study |
| PTS |
Post‐thrombotic syndrome |
| RCT |
Randomized controlled trial |
| V/Q |
Ventilation‐perfusion |
| 20LNG |
20 μg ethinylestradiol with levonorgestrel |
| 30LNG |
30 μg ethinylestradiol with levonorgestrel |
| 50LNG |
50 μg ethinylestradiol with levonorgestrel |
| 20GSD |
20 μg ethinylestradiol with gestodene |
| 30GSD |
30 μg ethinylestradiol with gestodene |
| 20DSG |
20 μg ethinylestradiol with desogestrel |
| 30DSG |
30 μg ethinylestradiol with desogestrel |
| 35NRG |
35 μg ethinylestradiol with norgestimate |
| 35CPA |
35 μg ethinylestradiol with cyproterone acetate |
| 30DRSP |
30 μg ethinylestradiol with drospirenone |
